May 14, 2020
We are currently working remotely to fulfill online contact lens orders. You can contact us directly about your prescription and ordering a new supply of contact lenses. We are working to make sure our contact lens catalogue and pricing is accessible. We’re also available to help you with your prescription and finding the right option for your current needs.
Spadina Optometry is not yet open for in-person, non-urgent business. We are providing only URGENT CARE in-person at this time.
On May 14, 2020, the provincial government announced it was moving forward with Phase I of its framework to return to business, however, the directive that prevents optometrists and other health care providers from providing non-urgent (routine) care in person is still in place. Optometry offices are not yet open for in-person, non-urgent business. Optometry offices are starting to prepare for the eventual return to non-urgent care, and the College has provided optometrists with guidance to help with this transition.College of Optometrists of Ontario
We are providing in-person urgent care. Please contact us to make arrangements for a tele-optometry consultation.
Our offices are preparing for the eventual return to non-urgent care, following the guidance provided by the College of Optometrists to help with this transition back to seeing patients.
OTTAWA – Health Canada is warning consumers not to use Lot 51436 of the product Genteal Artificial Tears 25 ml due to possible contamination with bacteria. A recall of the affected lot has been initiated by the distributor, Novartis.
Use of eye drops contaminated with bacteria may cause serious eye infection. People who are immune suppressed, such as those with HIV/AIDS, or who are undergoing chemotherapy or taking drugs which cause immune suppression may be at a higher risk for infection.
The product, with an expiry date of 2008-08, is fabricated by CIBA Vision Canada Inc., Sterile Manufacturing.
Lot numbers can usually be found on the top of the box or front panel of the bottle. The Drug Identification Number (DIN) for this product is 02231289. The DIN can be found on the front panel of the product label and outer packaging.
This product is used to relieve eye irritation or dryness and is sold without a prescription as an over-the-counter drug. It is widely available and is distributed across Canada. According to the company, the product was tested prior to release for sale and met all specifications, including sterility. However, the company advised Health Canada that it is recalling the product as a precautionary measure based on a recent review of the production facility controls.
Health Canada is advising consumers who use Genteal Artificial Tears to check the lot number on the bottle. If it is Lot 51436, with an expiry date of 2008-08, they should immediately stop using the product and return it where it was purchased. People using the affected lot who experience symptoms of eye infection such as redness, swelling, discharge, pain, itchiness, increased sensitivity to light and change in vision should seek medical attention.
Health Canada will update this advisory as soon as additional information is available. Health Canada advisories are posted at the following web address: http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/2005/index_e.html
Effective November 1, 2004
Routine eye exams, provided by either an optometrist or physician, for patients aged 20 to 64 are no longer covered by OHIP. These individuals will now pay for this service or have the cost of exams covered by private insurance.
Eye Care Services Covered by OHIP
- Changes will not affect seniors or those under age 20. People 65 and older and under 20 will continue to have OHIP coverage for a routine eye exam once every 12 months.
- Changes will not affect ophthalmology services for patients of any age with medical conditions or diseases affecting the eyes.
- All persons receiving assistance under the Ontario Disability Support Program, Ontario Works or the Family Benefits Program will continue to receive coverage for routine eye exams once every two years.
Increased Coverage for People with Medical Conditions
OHIP is increasing coverage for patients aged 20 to 64 years with medical conditions affecting the eye.
- Patients can receive a regular eye exam once every 12 months. Prior to November 1, 2004, eye exams were covered once every two years.
- Patients with any of the following conditions can go directly to their optometrist or physician to receive an OHIP-insured eye exam:
- Diabetes mellitus
- Retinal disease
- Visual field defects
- Corneal disease
- Patients aged 20 to 64 who have conditions not listed above may also be covered for a regular eye exam. They should discuss this with their primary healthcare provider.